2509 — Qyuns Therapeutics Co Cashflow Statement
0.000.00%
Last trade - 00:00- HK$4.48bn
- HK$3.94bn
- CNY806.96m
Annual cashflow statement for Qyuns Therapeutics Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -427 | -312 | -521 | -350 | — |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 259 | 29.8 | 138 | 82.9 | — |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 19.6 | 26.9 | 50 | 48.1 | 400 |
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -123 | -225 | -301 | -186 | 400 |
| Capital Expenditures | -58.9 | -22.8 | -7.95 | -1.76 | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -188 | 17.1 | 251 | -23.5 | 119 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -247 | -5.7 | 243 | -25.2 | 119 |
| Financing Cash Flow Items | 284 | -15.9 | -15.2 | -18.3 | 93.7 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 281 | 211 | 61.2 | 352 | 93.7 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -91.2 | -4.96 | 3.21 | 144 | 601 |